Recherche de *.

1. PANACEA2 Genomics (Projects)

   PANACEA2 Genomics

   Pertinence:
   https://www.swisstph.ch/fr/projects/project-detail/project/panacea2-genomics

   The PANACEA2 Consortium is testing new drugs and treatment regimens against tuberculisis (TB) in various African countries. Our role in this consortium is to use next-generation genome seqeuncing to s

2. Performance of Cepheid GeneXpert® Omni for early detection of tuberculosis and multidrug resistant tuberculosis in adults with presumptive pulmonary... (Projects)

   Performance of Cepheid GeneXpert® Omni for early detection of tuberculosis and multidrug resistant tuberculosis in adults with presumptive pulmonary tuberculosis at Primary Health Care facilities in Georgia in a controlled phased pre and post intervention

   Pertinence:
   https://www.swisstph.ch/fr/projects/project-detail/project/performance-of-cepheid-genexpertr-omni-for-early-detection-of-tuberculosis-and-multidrug-resistant-tuberculosis-in-adults-with-presumptive-pulmonary-tuberculosis-at-primary-health-care-facilities-in-georgia-in-a-controlled-phased-pre-and-post-intervention

   Tuberculosis (TB) still remains a major global challenge. In 2017, there were estimated10million new cases globally. Same year 16% of people with TB has died from the disease. In the same year, 6.4 mi

3. Impact Evaluation Baseline Survey Integrated WASH/Cash Transfer Program in Niger (Sahel Adaptive Safety Net Program) (Projects)

   Impact Evaluation Baseline Survey Integrated WASH/Cash Transfer Program in Niger (Sahel Adaptive Safety Net Program)

   Pertinence:
   https://www.swisstph.ch/fr/projects/project-detail/project/impact-evaluation-baseline-survey-integrated-wash/cash-transfer-program-in-niger-sahel-adaptive-safety-net-program

   SCIH/Swiss TPH was mandated by the World Bank with the implementation of the survey “Baseline Survey for the Impact Evaluation of the Integrated WASH/Cash Transfer program in Niger”. The national sub-

4. UNICEF’s Assessment of East Asia and Pacific Regional Situation and Key Areas in Gender-Responsive Adolescent Health (GRAH) (Projects)

   UNICEF’s Assessment of East Asia and Pacific Regional Situation and Key Areas in Gender-Responsive Adolescent Health (GRAH)

   Pertinence:
   https://www.swisstph.ch/fr/projects/project-detail/project/unicefs-assessment-of-east-asia-and-pacific-regional-situation-and-key-areas-in-gender-responsive-adolescent-health-grah

   The Young Child Survival Development and Gender Sections of UNICEF’s East Asia and Pacific Regional Office commissioned a regional assessment of adolescent health to facilitate the operationalization

5. Health impact assessment for engaging natural resource extraction projects in sustainable development in producer regions (Projects)

   Health impact assessment for engaging natural resource extraction projects in sustainable development in producer regions

   Pertinence:
   https://www.swisstph.ch/fr/projects/hia4sd

   The development and operation of natural resource extraction projects (e.g. minerals, metals, oil and gas) affects public health, ecosystems and societies in producer regions. The HIA4SD Project inten

6. Enhancing Primary Health Care Services Project, Tajikistan (Projects)

   Enhancing Primary Health Care Services Project, Tajikistan

   Pertinence:
   https://www.swisstph.ch/fr/projects/project-detail/project/enhancing-primary-health-care-services-project-tajikistan

   Background The Swiss Agency for Development and Cooperation's Enhancing Primary Health Care (PHC) project is implemented by the Swiss Tropical and Public Health Institute in consortium with Save the C

7. Capacity building in health impact assessment (HIA) training and research in Vietnam (Projects)

   Capacity building in health impact assessment (HIA) training and research in Vietnam

   Pertinence:
   https://www.swisstph.ch/fr/projects/project-detail/project/capacity-building-in-health-impact-assessment-hia-training-and-research-in-vietnam

   Health impact assessment (HIA) is an interdisciplinary approach that aims at predicting and managing potential positive and negative health effects of policies, programmes, and projects on affected co

8. Efficacy and safety of fexinidazole in patients with Human African Trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense: a multicentre,... (Projects)

   Efficacy and safety of fexinidazole in patients with Human African Trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense: a multicentre, open-label clinical trial

   Pertinence:
   https://www.swisstph.ch/fr/projects/project-detail/project/efficacy-and-safety-of-fexinidazole-in-patients-with-human-african-trypanosomiasis-hat-due-to-trypanosoma-brucei-rhodesiense-a-multicentre-open-label-clinical-trial

   A vector-borne parasitic illness, human African trypanosomiasis (HAT), also known as sleeping sickness, is usually fatal without treatment. The less prevalent form, T.b. rhodesiense (r-HAT), is concen

9. Evolution and Epidemiology of Rifampicin-Resistant Tuberculosis in Khayelitsha, Cape Town: Implications for Biology and Disease Control (Projects)

   Evolution and Epidemiology of Rifampicin-Resistant Tuberculosis in Khayelitsha, Cape Town: Implications for Biology and Disease Control

   Pertinence:
   https://www.swisstph.ch/fr/projects/project-detail/project/evolution-and-epidemiology-of-rifampicin-resistant-tuberculosis-in-khayelitsha-cape-town-implications-for-biology-and-disease-control

   Background Bacteria resistant to multiple antibiotics are a growing threat for global public health and the economy. Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant TB (XDR-TB

10. Drug discovery and development for schistosomiasis: From repositioning of antimalarial drug leads and clinical advanced drug candidates to the... (Projects)

    Drug discovery and development for schistosomiasis: From repositioning of antimalarial drug leads and clinical advanced drug candidates to the development of a new paediatric formulation of praziquantel

    Pertinence:
    https://www.swisstph.ch/fr/projects/project-detail/project/drug-discovery-and-development-for-schistosomiasis-from-repositioning-of-antimalarial-drug-leads-and-clinical-advanced-drug-candidates-to-the-development-of-a-new-paediatric-formulation-of-praziquantel

    The aim of my 4-year research project is to identify one or several antischistosomal drug development candidates targeting the haemoglobin degradation pathway and/or other mechanisms with favourable p